MLYS vs TM · $2.17B cap vs P/E 9.7, rev $234.60B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
MLYS does not have a complete income-statement cache yet.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
MLYS currently screens at market cap $2.17B. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the MLYS and TM stock pages for the full models.
Not investment advice.